DrugDashboards

Market view

sulfamethoxazole and trimethoprim · Injection, Solution, Concentrate

9 marketed package NDCs · 2 active manufacturers

Most dispensed: 200 mg/5mL; 40 mg/5mL · Suspension · #473 mL/bottle · 800 mg; 160 mg · Tablet · #500 tablets/bottle · 400 mg; 80 mg · Tablet · #500 tablets/bottle · 800 mg; 160 mg · Tablet · #100 tablets/bottle

All formsTablet (257)Suspension (24)Injection, Solution, Concentrate (9)

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for sulfamethoxazole and trimethoprim, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Dihydrofolate Reductase Inhibitor Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Sulfamethoxazole and trimethoprim in shortage right now?
No. FDA does not currently list Sulfamethoxazole and trimethoprim in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Sulfamethoxazole and trimethoprim?
45 companies have marketed Sulfamethoxazole and trimethoprim in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Sulfamethoxazole and trimethoprim cost?
The typical pharmacy pays about $0.0448 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.